0.9% Sodium Chloride Injection USP Shortage: Current Status and Information
An active shortage has been reported for 0.9% Sodium Chloride Injection USP, a critical medical fluid used for hydration and medication delivery.
What’s in Shortage
The medication currently in shortage is 0.9% Sodium Chloride Injection USP. This product is a sterile solution typically used for intravenous administration. The current status of this shortage is listed as Active.
Which Manufacturers Are Affected
At this time, the source data does not specify individual manufacturers or their specific availability statuses for this report (Shortage ID: 34506). No specific Drug Identification Number (DIN) or company contact information was provided in the current listing.
Why There’s a Shortage
No specific reason for the shortage of 0.9% Sodium Chloride Injection USP was provided in the source report.
What Patients Should Do
If you are a patient or caregiver concerned about the availability of this medication, please take the following steps:
- Consult Your Healthcare Provider: Speak with your doctor or the clinical staff at your treatment facility to discuss how this shortage may impact your care.
- Talk to Your Pharmacist: Pharmacists can provide information on current stock levels and supply chain updates.
- Inquire About Alternatives: Ask your medical team if there are appropriate alternative treatments or protocols available during this period.
Disclaimer: Patients should always consult their healthcare provider regarding medical decisions and treatment alternatives. Do not attempt to substitute medications without professional medical guidance.
Source
Information attributed to the Drug Shortages Canada database (Shortage ID: 34506). For the most recent updates, visit the official report.
Related Articles
0.9% Sodium Chloride Injection Shortage Reported
Drug Shortages Canada · February 16, 2026
0.9% Sodium Chloride Injection Shortage: Current Status and Information
Drug Shortages Canada · February 16, 2026
0.9% Sodium Chloride Injection, USP Facing Active Shortage
Drug Shortages Canada · February 16, 2026